Hemorrhagic cystitis (HC) is a known complication of stem cell transplantation. In contrast to early-onset HC that is usually attributed to cyclophosphamide and occurs within a few days of infusion, late onset HC is associated with viral infection. In recent years BK virus has emerged as an important causative agent. We describe two patients who developed late onset HC (38 and 92 days post transplant) associated with BK viruria concomitant with CMV reactivation and suggest a possible role of CMV in the process of BK virus DNA replication. Bone Marrow Transplantation (2001) 28, 613-614. Keywords: BK virus-associated hemorrhagic cystitis; CMV reactivation; peripheral blood stem cell transplantation An association between BK viruria and hemorrhagic cystitis (HC) in recipients of bone marrow transplants was first described by Arthur et al. 1 Since then, an increasing number of reports has identified the BK virus as the most common pathogen in late onset HC post BMT.
An association between BK viruria and hemorrhagic cystitis (HC) in recipients of bone marrow transplants was first described by Arthur et al. 1 Since then, an increasing number of reports has identified the BK virus as the most common pathogen in late onset HC post BMT. [2] [3] [4] [5] Association of CMV infection with HC was described by Spach et al 6 and a trend towards a higher incidence of HC in patients with reactivation of CMV was reported in a group of patients receiving T cell-depleted allografts. 7 Recently, a case of BK virus-associated HC and simultaneous CMV reactivation was described which was successfully treated with cidofovir directed against both the BK virus and the CMV. 8 Both CMV and BK viruses are highly prevalent in the population. Primary infection is usually asymptomatic in the immunocompetent host. Afterwards the viruses can persist in a latent state in the kidney or other sites. Reactivation occurs as a consequence of immunosuppression, as is the case after hematopoietic stem cell transplantation. CMV induces JC virus DNA replication in human fibroblasts and ganciclovir that inhibits CMV replication is associated with concomitant inhibition of JC virus replication. 9 JC virus is a member of the human polyomavirus family which is closely related to BK virus.
Based on the interaction between CMV and JC virus (another member of the human polyomavirus family) we suggest an explanation for the temporal association between CMV reactivation and the occurrence of BK virus-associated late-onset HC and emphasize the role of ganciclovir in controlling both infections.
Case 1
A 4-year-old male with X-linked chronic granulomatous disease underwent peripheral blood stem cell (PBSC) transplantation from his HLA-identical brother in December 1998. The patient had pulmonary aspergillosis and was treated with liposomal amphotericin and granulocyte transfusions as previously described. 10 The conditioning regimen included busulfan, cyclophosphamide and ATG. GVHD prophylaxis consisted of cyclosporine and short course MTX. Both donor and recipient were CMV seropositive.
The patient had rapid engraftment and there were no major complications during the transplant period. On day 60 post-transplant, he developed grade III skin GVHD that was treated with high-dose corticosteroids, cyclosporine, ATG and mycophenolate and which gradually resolved. On day 92 post-transplant he developed grade III HC. BK virus was identified in the urine by PCR for early gene using a specific PCR primer pair for BK virus. Reactivation of CMV was detected by positive antigenemia and CMV was also found in the urine culture taken at the onset of HC. Treatment with ganciclovir was initiated along with aggressive hydration, which resulted in resolution of the HC within a month. CMV became negative within 12 days.
Case 2
A 6.-year-old boy with very slowly responsive ALL in first remission underwent PBSC transplantation from a matched unrelated donor in October 2000. The conditioning regimen included busulfan and cyclophosphamide and GVHD prophylaxis consisted of cyclosporine and short course MTX. Both donor and recipient were CMV seropositive. His clinical course was uneventful and he had engrafted by day 16. On day 30 post-transplant he developed grade II skin GVHD and was treated with corticosteroids. On day 38 post-transplant he developed grade III HC. BK virus was identified in the urine by PCR for the early gene using a specific PCR primer pair for BK virus. Reactivation of CMV was detected by positive antigenemia. The patient was treated with ganciclovir and hydration. Resolution of the HC occurred within 11 days and CMV antigenemia was negative within 7 days of treatment with ganciclovir.
Discussion
Late-onset HC post BMT is generally associated with viral infection. Several studies have demonstrated that reactivation of the BK polyomavirus is an important pathogen in the development of HC post BMT. [2] [3] [4] [5] An association between reactivation of CMV and late-onset BK virus-associated HC was recently described in recipients of allogeneic BMT 8 and a trend towards a higher incidence of HC in patients with reactivation of CMV was described in T celldepleted BMT recipients. 7 BK virus and JC virus are members of the human polyomaviruses, and each is 70% homologous with the other. Both viruses can cause infections in the immunocompromised host due to reactivation. JC virus is associated with the progressive multifocal leukoencephalopathy seen in HIV patients, and persistent BK virus replication was described as an important cause of nephropathy in renal allograft recipients.
11 DNA viruses (herpes simplex virus, CMV) have been shown to induce amplification of polyomaviruses in tissue cultures.
12, 13 Heilbronn et al have showed that CMV induces JC virus DNA replication and that ganciclovir-induced inhibition of CMV replication was associated with a concomitant inhibition of JC virus replication. 9 The temporal association between BK virus-associated HC and reactivation of CMV in the two patients described above led us to hypothesize that as in the case of JC virus, CMV was responsible for the replication of the BK virus and for the resultant HC. Treatment with ganciclovir controlled the CMV infection and as a consequence of inhibition of the BK virus replication resolution of the HC symptoms occurred. However, BK virus could still be detected in the urine after recovery as has been reported in the literature. [3] [4] [5] In both cases, GVHD preceded the HC and the immunosuppressive therapy could have had a role in the reactivation of both viruses. GVHD is considered a risk factor for the development of HC by several authors. 2, 14 In light of the presumed mechanism for the role of CMV in inducing BK virus-associated HC, we suggest that treatment with ganciclovir can control CMV infection and lead to resolution of HC. More epidemiological and clinical studies are required to support the association between CMV infection and BK virus-associated HC in the setting of stem cell transplantation.
